Cervix cancer;Cancer du col utérin

Cancer/Radiotherapie

Volumn 14, Issue SUPPL. 1, 2010, Pages

  Pointreau, Y ^a,b,c,d   Ruffier Loubiere A ^a   Denis, F ^e   Barillot, I ^a,b  

^a CHU BRETONNEAU   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c CNRS   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e CENTRE JEAN BERNARD   (France)

Author keywords

Atlas; Cervix cancer; Conformal radiotherapy; Target volumes

Indexed keywords

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; FEMALE; HUMAN; LYMPH NODE; PRIORITY JOURNAL; TREATMENT INDICATION; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; CERVIX UTERI; COMBINED MODALITY THERAPY; DEVELOPED COUNTRIES; FEMALE; HUMANS; INCIDENCE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; UTERINE CERVICAL NEOPLASMS;

EID: 78649793699     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(10)70018-4     Document Type: Article

References (25)

1. Barillot I. Les cancers du col utérin: place de la radiothérapie avec modulation d'intensité. Cancer Radiother 2009, 13:507-510.
2. Barre S. Stratégies de dépistage du cancer du col de l'utérus en France en 2009, Service évaluation Economique et Santé publique, HAS:. http://www.has-sante.fr/.
3. Benedet J.L., Bender H., Jones H., Ngan H.Y., Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000, 70:209-262.
4. Buchali A., Koswig S., Dinges S., Rosenthal P., Salk J., Lackner G., et al. Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynaecological cancer. Radiother Oncol 1999, 52:29-34.
5. Chavaudra J., Bridier A. Définition des volumes en radiothérapie externe: rapports ICRU 50 et 62. Cancer Radiother 2001, 5:472-478.
6. Duport N. Données épidémiologique sur le cancer du col de l'utérus- état des connaissances- actualisation 2008- Institut de Veille Sanitaire. http://www.invs.sante.fr/.../2008/cancer_col_uterus_2008/cancer_col_uterus_2008.%20pdf.
7. Eifel P.J., Winter K., Morris M., Levenback C., Grigsby P.W., Cooper J., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004, 22:872-880.
8. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009, 105:10-14. FIGO Committee on Gynecologic Oncology.
9. Finlay M.H., Ackerman I., Tirona R.G., Hamilton P., Barbera L., Thomas G. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks. Int J Radiat Oncol Biol Phys 2006, 64:205-209.
10. Gérard JP, Ortholan C, Pointreau Y, (eds). Guide des procédures de radiothérapie externe 2007 - SFRO. Cancer Radiother 2008; 12:3-4.
11. Dose de tolérance à l'irradiation des tissus sains. Cancer Radiother 2010; 4-5:227-410.
12. Huh S.J., Park W., Han Y. Interfractional variation in position of the uterus during radical radiotherapy for cervical cancer. Radiother Oncol 2004, 71:73-79.
13. Kim R.Y., McGinnis L.S., Spencer S.A., Meredith R.F., Jennelle R.L., Salter M.M. Conventional four-field pelvic radiotherapy technique without computed tomography-treatment planning in cancer of the cervix: potential geographic miss and its impact on pelvic control. Int J Radiat Oncol Biol Phys 1995, 31:109-112.
14. Kim R.Y., McGinnis L.S., Spencer S.A., Meredith R.F., Jennelle R.L., Salter M.M. Conventional four-field pelvic radiotherapy technique without CT treatment planning in cancer of the cervix: potential geographic miss. Radiother Oncol 1994, 30:140-145.
15. Blaustein's pathology of the female genital tract 2001, 781-904. SpringerVerlag. 5th ed. R.J. Kurman (Ed.).
16. Mitine C., Hoornaert M.T., Dutreix A., Beauduin M. Radiotherapy of pelvic malignancies: impact of two types of rigid immobilisation devices on localisation errors. Radiother Oncol 1999, 52:19-27.
17. Mortier D.G., Stroobants S., Amant F., Neven P., Van Limbergen E., Vergote I. Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB. Int J Gynecol Cancer 2008, 18:723-729.
18. Pecorelli S. Corrigendum to " Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium" Int J Gynaecol Obstet 2010, 108:176.
19. Perez C.A., Grigsby P.W., Castro-Vita H., Lockett M.A. Carcinoma of the uterine cervix.II. Lack of impact of prolongation of overall treatment time on morbidity of radiation therapy. Int J Radiat Oncol Biol Phys 1996, 34:3-11.
20. Robboy S.J., Anderson M.C., Russel P. Pathology of the female reproductive tract 2002, Churchill livingstone, London, 567-569.
21. Rotman M., Aziz H., Eifel P.J. Irradiation of Pelvic and Para-Aortic Nodes in Carcinoma of the Cervix. Semin Radiat Oncol 1994, 4:23-29.
22. Rotman M., Choi K., Pajak T., Clery M., Marcial V., Grigsby P.W., et al. Prophylactic Extended Field Irradiation of the Para-Aortic Lymph Node Chain in Stage IIB and Selected Stage IB and IIA Carcinomas of the Cervix. 10-Yr Treatment Results of RTOG 79-20. JAMA/Jama 1995, 274:387-393.
23. Stroom J.C., Olofsen-van Acht M.J., Quint S., Seven M., de Hoog M., Creutzberg C.L., et al. On-line set-up corrections during radiotherapy of patients with gynecologic tumors. Int J Radiat Oncol Biol Phys 2000, 46:499-506.
24. van de Bunt L., Jürgenliemk-Schulz I.M., de Kort G.A., Roesink J.M., Tersteeg R.J., van der Heide U.A. Motion and deformation of the target volumes during IMRT for cervical cancer: what margins do we need?. Radiother Oncol 2008, 88:233-240.
25. http://www.icru.org/.